Healthcare costs are rising, but are the reasons valid? In this episode, Dr. Manfred Stapff examines UnitedHealthcare's proposed 18% rate hike and asks: where's the evidence?

Using authoritative data from CMS and PricewaterhouseCoopers, Dr. Manfred reveals how this price increase sharply diverges from national healthcare cost trends. He confronts the growing tension between record-breaking profits and patient affordability, and challenges the flawed logic of treating healthcare as a free-market commodity.

With clarity and depth, this episode equips listeners to question inflated costs, analyze systemic inefficiencies, and rethink the incentives behind our healthcare decisions.

Gain sharper insight into how science—not speculation—should shape the future of healthcare. Tune in to the episode: Beyond the 18% Hike: What's Broken in the Health Care System of UnitedHealthcare.

Dr. Manfred Stapff is an entrepreneurial biotech and pharmaceutical expert with deep expertise in real-world evidence and clinical research. As a seasoned leader, he brings decades of experience across all phases of drug development—from opportunity assessment to product launch. His work bridges science and strategy, ensuring medical decisions are grounded in accurate, meaningful data. Dr. Stapff is also an author, committed to promoting evidence-based thinking in medicine. His insights challenge misinformation and advocate for scientific integrity in today's data-driven world.

Connect with Dr. Manfred Stapff, MD:

LinkedIn: https://www.linkedin.com/in/manfredstapff/

Website: https://candid-advisory.com/